Doctors are positive about the SGLT-2 inhibitor…“Yet, it lacks in patient cases”
The treatment industry for ‘diabetes’, considered as one of the chronic diseases, has begun a new changing era. So far, the existing diabetes treatments have had side effects of weight increases and hypoglycemia.
However, as the ‘SGLT-2 inhibitor’ has been launched along with the ‘DPP-4 inhibito...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
